Drug class

Attention Deficit Hyperactivity Disorder (ADHD) Agents

Attention Deficit Hyperactivity Disorder (ADHD) Agents comprise a therapeutic drug class utilized to manage the core symptoms of ADHD, including inattention, impulsivity, and hyperactivity. Read more about Attention Deficit Hyperactivity Disorder (ADHD) Agents

261 drugs in this class 104 manufacturers

Advertisement

Drugs in Attention Deficit Hyperactivity Disorder (ADHD) Agents

Showing 181–189 of 261 drugs

DEXMETHYLPHENIDATE HCL

AMPHETAMINES/ANOREXIANTS/STIMULANTS · ATTENTION-DEFICIT HYPERACTIVITY DISORDER
ASCEND LABORATO

METHYLPHENIDATE HCL

AMPHETAMINES/ANOREXIANTS/STIMULANTS · ATTENTION-DEFICIT HYPERACTIVITY DISORDER ·+1
ASCEND LABORATO
Filter & compare in the drug finder → Opens the drug finder with Attention Deficit Hyperactivity Disorder (ADHD) Agents preselected. Add indication or manufacturer filters there.

About Attention Deficit Hyperactivity Disorder (ADHD) Agents.

Attention Deficit Hyperactivity Disorder (ADHD) Agents comprise a therapeutic drug class utilized to manage the core symptoms of ADHD, including inattention, impulsivity, and hyperactivity.

This class encompasses both central nervous system stimulants, such as amphetamines and methylphenidate derivatives, and non-stimulant medications, including selective norepinephrine reuptake inhibitors and central alpha-2 adrenergic agonists.

Mechanistically, these agents enhance prefrontal cortical functioning and neurotransmission by increasing extracellular levels or signaling of norepinephrine and dopamine.

Beyond their primary indication for ADHD in pediatric and adult populations, select agents within this class carry approved indications for conditions such as narcolepsy and binge eating disorder.